PTNS, or percutaneous tibial nerve stimulation, is a minimally invasive treatment for overactive bladder that uses mild electrical pulses delivered through a thin needle near the ankle. It’s FDA-cleared to treat urinary urgency, urinary frequency, and urge incontinence. The treatment works by stimulating a nerve in your lower leg that connects back to the same spinal nerves controlling your bladder, essentially recalibrating the signals that cause those sudden, hard-to-ignore urges to urinate.
How PTNS Works
The posterior tibial nerve runs from your lower spine down through your leg to your ankle. It branches off from the sciatic nerve and shares roots with the sacral nerve plexus, which is the cluster of nerves in your lower back that controls bladder function. When electrical stimulation travels up the tibial nerve, it reaches that same nerve cluster and changes the way signals are transmitted to and from your bladder. This is called retrograde neuromodulation: sending a corrective signal backward along the nerve pathway to calm overactive bladder reflexes at their source.
Think of it as adjusting the volume knob on a misfiring nerve signal. In people with overactive bladder, the nerves controlling the bladder muscle send “time to go” signals too frequently or too urgently. PTNS dials those signals down without surgery, medication, or any permanent changes to your body.
What a Session Feels Like
Each PTNS session takes about 30 minutes. A healthcare provider inserts a very thin needle near your inner ankle, close to the posterior tibial nerve. A small device then sends gentle electrical pulses through the needle. Most people feel a tingling sensation or mild pulsing in the foot or toes during stimulation. Some experience a slight ache or tightness in the leg. The sensation is generally well tolerated, and the needle used is much thinner than what you’d encounter with a typical blood draw.
You sit in a chair or recline during the session, and you can read, scroll your phone, or just relax. There’s no sedation, no recovery time, and you can drive yourself home and resume normal activities immediately afterward.
The Standard Treatment Schedule
The initial course of PTNS is 12 weekly sessions. You go in once a week, every week, for about three months. This induction phase gives the nerve stimulation enough cumulative exposure to produce lasting changes in bladder signaling. Some newer research suggests that as few as six sessions may begin to provide meaningful symptom relief, but the 10 to 12 session protocol remains the clinical standard.
After completing the initial course, most people who respond well transition to maintenance sessions. The frequency varies based on how your symptoms behave, but once a month is a common schedule. Without maintenance, symptoms tend to return over time because PTNS doesn’t permanently rewire the nerve pathways. It manages them through ongoing, periodic stimulation.
A long-term study tracking over 400 patients found that maintenance treatment was typically guided by individual symptoms rather than a rigid calendar. Some people could stretch sessions further apart, while others needed them a bit more frequently.
How Effective PTNS Is
Across multiple studies, between 54% and 80% of patients with overactive bladder are classified as successfully treated with PTNS. “Successfully treated” generally means a meaningful reduction in urgency episodes, fewer daily trips to the bathroom, and improved quality of life scores.
One well-designed placebo-controlled trial put those numbers in sharper focus. Patients receiving real PTNS were compared against a group receiving sham stimulation. Among those getting actual treatment, 71% achieved a greater than 50% reduction in urge incontinence episodes. In the placebo group, that number was 0%. The improvements in incontinence episodes, number of daily voids, and quality of life were all statistically significant in the PTNS group but not in the placebo group, which confirms the treatment effect is genuine and not just a placebo response.
How PTNS Compares to Other Treatments
A large network meta-analysis comparing all major overactive bladder treatments found that PTNS performs similarly to the two most common medication classes (antimuscarinics and beta-3 agonists) for reducing urinary frequency and urgency. For reducing incontinence episodes specifically, PTNS ranked among the top three treatments alongside bladder injections and surgically implanted sacral nerve stimulators.
The key advantage of PTNS over medications is the side effect profile. Antimuscarinic drugs commonly cause dry mouth and constipation, which leads many people to stop taking them. Beta-3 agonist medications can raise blood pressure over time. PTNS side effects are limited to occasional mild discomfort, tingling, or soreness at the needle site. No systemic side effects means much better long-term adherence for people who respond to the treatment.
The tradeoff is convenience. Medications are a daily pill at home. PTNS requires regular office visits, which can be a barrier for people with demanding schedules or limited transportation. More invasive options like sacral neuromodulation (a surgically implanted device) and bladder injections tend to produce larger symptom reductions, but they come with surgical risks, anesthesia, and in the case of injections, the possibility of temporary difficulty emptying the bladder.
Who Should Not Have PTNS
PTNS is not appropriate for everyone. People with pacemakers or implantable defibrillators cannot receive the treatment because the electrical stimulation could interfere with those devices. It is also contraindicated during pregnancy and in people with bleeding disorders (coagulopathy), since the treatment involves needle insertion.
PTNS is typically offered after behavioral strategies like bladder retraining and pelvic floor exercises have been tried, and either alongside or after medications have been attempted. It sits in a middle ground between conservative approaches and more invasive surgical options.
Cost and Insurance
Medicare and many private insurers cover PTNS for voiding dysfunction, though coverage requirements vary. Some insurers require documentation that you’ve tried and failed at least one medication before approving PTNS. Because the treatment involves 12 initial visits plus ongoing maintenance, the total commitment is higher than a prescription but lower than a surgical procedure. Check with your specific plan, as prior authorization is commonly required.